Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow, Internal Medicine, University Hospitals of Cleveland 1987 - 1990
  • Resident, Internal Medicine, University Hospitals of Cleveland 1985 - 1987
  • Intern, Internal Medicine, University Hospitals of Cleveland 1984 - 1985
  • M.D., Duke University 1984
• 

  Duke Appointment History

  • Consulting Associate in the Department of Medicine, Medicine, Medical Oncology, Medicine 1998 - 2008
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 1998
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Gasparetto, C, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Long, GD, Horwitz, ME, Keogh, G, Chute, JP, Sullivan, KM, Neuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, NJ, and Rizzieri, D. ""Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma." Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70-77.  Full Text  Link to Item
    • Sedwick, WD, Anderson, RD, Baxter, J, Donover, S, Schneiter, S, and Veigl, ML. "Correlation of doxorubicin footprints with deletion endpoints in lacO of E. coli." Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 326, no. 1 (1995): 17-27.  Full Text
    • Veigl, ML, Donover, SP, Anderson, RD, Akst, L, Sedwick, CE, and Sedwick, WD. "Effect of isopropyl-β-D-thiogalactopyranosid induction of the lac operon on the specificity of spontaneous and doxorubicin-induced mutations in Escherichia coli." Environmental and Molecular Mutagenesis 26, no. 1 (1995): 16-25.  Full Text
    • Anderson, RD, and Berger, NA. "Mutagenicity and carcinogenicity of topoisomerase-interactive agents." Mutation Research Regular Papers 309, no. 1 (1994): 109-142.  Full Text
    • Anderson, RD, Bao, C-Y, Minnick, DT, Baxter, J, Veigl, ML, and Sedwick, WD. "Sequencing of double-stranded polymerase chain reaction products for mutation analysis." Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 288, no. 1 (1993): 181-185.  Full Text
    • Anderson, RD, Veigl, ML, Baxter, J, and Sedwick, WD. "Excision repair reduces doxorubicin-induced genotoxicity." Mutation Research-DNA Repair 294, no. 3 (1993): 215-222.  Full Text
    • Anderson, RD, Veigl, ML, Baxter, J, and Sedwick, WD. "DNA sequence specificity of doxorubicin-induced mutational damage in uvrB^- Escherichia coli." Cancer Research 51, no. 15 (1991): 3930-3937.
    • Anderson, RD, Veigl, ML, and Sedwick, WD. "Rapid mapping of deletion and duplication mutations by the polymerase chain reaction." Biochemical and Biophysical Research Communications 170, no. 2 (1990): 416-420.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.